Abstract:
Although the presence of morphea following COVID-19 has been rarely
reported, development of its generalized form following COVID-19
vaccination has not been reported yet. Here, we reported the first case
of generalized morphea following COVID-19 vaccination and another
similar case following SARS-Cov-2 infection. Other etiologic factors
were also dealt with.
Key Words: Morphea; COVID; COVID vaccination; AstraZeneca;
SARS-Cov-2